Component-resolved diagnosis in allergic disease: Utility and limitations
Loading...
Download
Official URL
Full text at PDC
Publication date
2019
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
ELSEVIER
Citation
San Miguel-Rodríguez A, Armentia A, Martín-Armentia S, Martín-Armentia B, Corell A, Lozano-Estevan MC, et al. Component-resolved diagnosis in allergic disease: Utility and limitations. Clinica Chimica Acta [Internet]. febrero de 2019 [citado 29 de enero de 2025];489:219-24. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0009898118303978
Abstract
Component resolved diagnosis (CRD) is a microarray-based diagnostic solution capable of simultaneously analysing specific IgE antibodies against 112 allergenic components, providing sensitivity patterns for multisensitised or complex patients. The CRD is indicated for these patients, especially those with concomitant respiratory and food allergies. This study reivews the method, its utility, limitations, and our experience in allergic diseases with difficult etiologic diagnosis (eosinophilic esophagitis, occupational asthma and drug allergy).